Senior insider sale
Chief Executive Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$6.75M
75K shares
What this filing means
TURTLE CAMERON plans to sell 75K shares of SPYRE THERAPEUTICS, INC. valued at approximately $6.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2026ACC: 0001950047-26-009978
DirectorOfficer· Chief Executive Officer
Since Mar 2026
75K
Shares to sell
$6.75M
Approx. market value
45K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
N/A
6/15/2023
45KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2023 | Previously Exercised Stock Options N/A | 45K | — |
| Total | 45K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
15K
Market value
$1.31M
9/1/2026
—Completed
Units to sell
15K
Market value
$1.43M
8/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
45K
Market value
$4.01M
10/1/2026
Total
Units
75K
Value
$6.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 15K | $1.31M | — | Completed |
8/3/2026 | 15K | $1.43M | — | Completed |
| Planned — Approximate Date | ||||
10/1/2026 | 45K | $4.01M | NASDAQ | Planned |
| Total | 75K | $6.75M | ||